HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
NTLA holding history
Intellia Therapeutics, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings
- Shares (Q2 2026)
- 65
- Value
- $1.10K
- % of portfolio
- <0.1%
- Quarters held
- 20
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 65 | $1.10K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 65 | $834 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 65 | $585 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 65 | $1.12K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 65 | $610 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 65 | $463 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 65 | $758 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 65 | $1.34K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 65 | $1.46K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 65 | $1.79K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 65 | $1.98K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 65 | $2.06K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 65 | $2.65K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 65 | $2.42K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 65 | $2.27K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 65 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 65 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 65 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 65 | $8.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 65 | $9.00K | <0.1% | +65 | New | Holders |